Chronic Lung Disease in Medical Literature for More Than 200 Years Finally Has Its First Drug

Insmed’s Brinsupri is the first drug specifically approved for treating non-cystic fibrosis bronchiectasis, a progressive and potentially fatal lung disorder. The drug, licensed from AstraZeneca, inhibits activation of neutrophils, white blood cells that play a role in inflammatory and immune responses. The post Chronic Lung Disease in Medical Literature for More Than 200 Years Finally…

Read More

As Cannabis Users Age, Health Risks Appear To Grow

Benjamin Han, a geriatrician and addiction medicine specialist at the University of California-San Diego, tells his students a cautionary tale about a 76-year-old patient who, like many older people, struggled with insomnia. “She had problems falling asleep, and she’d wake up in the middle of the night,” he said. “So her daughter brought her some…

Read More

Healthcare Marketing: Key Trends Shaping 2025

From a marketing perspective, there are three significant trends to watch in 2025 — strategic brand partnerships, AI-driven healthcare information delivery, and the fundamental shift in social media engagement paradigms. The post Healthcare Marketing: Key Trends Shaping 2025 appeared first on MedCity News.

Read More